ProCE Banner Activity

ExpressPoints
Beyond BRCA: Exploring PARP Combinations in Prostate Cancer

Slideset Download
Download this brief summary slideset from a live Webinar to review the rationale for and most recent clinical data on PARP inhibitor combination therapy in metastatic CRPC.

Released: March 03, 2021

Expiration: March 02, 2022

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

AstraZeneca

Merck Sharp & Dohme Corp.

Pfizer TEXT Only

Faculty Disclosure

Primary Author

Charles Ryan, MD

Associate Clinical Professor
Department of Medicine Hematology/Oncology
University of California, San Francisco
San Francisco, California

Neal D. Shore, MD, FACS

Director
Carolina Urologic Research Center
Atlantic Urology Clinics
Myrtle Beach, South Carolina